The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2025 | Improving genomic testing turnaround for lung cancer to accelerate targeted treatment
Robert Rintoul, BSc, MB ChB, PhD, FRCP, University of Cambridge & Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK, discusses the UK Lung Cancer Coalition’s new report on genomic testing for lung cancer. The report highlights delays in the pathology and genomic medicine pathway, emphasizing the urgent need for a 14-day turnaround to ensure patients receive timely, targeted treatments. Prof. Rintoul outlines key challenges, regional best practices, and recommendations to streamline the process, improve efficiency, and ultimately save lives. This interview took place at the BTOG 2025 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Link to report: https://www.uklcc.org.uk/our-reports/march-2025/faster-testing-better-outcomes-genomic-testing-lung-cancer
